Seven Eight Capital LP Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Seven Eight Capital LP boosted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 57.9% in the second quarter, Holdings Channel.com reports. The firm owned 67,049 shares of the medical instruments supplier’s stock after acquiring an additional 24,584 shares during the period. Seven Eight Capital LP’s holdings in DENTSPLY SIRONA were worth $1,670,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Wahed Invest LLC boosted its holdings in shares of DENTSPLY SIRONA by 9.3% in the 4th quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier’s stock valued at $128,000 after buying an additional 306 shares during the period. Raymond James Trust N.A. boosted its stake in DENTSPLY SIRONA by 4.9% in the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after acquiring an additional 453 shares during the period. LRI Investments LLC grew its holdings in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the last quarter. Diversified Trust Co raised its position in shares of DENTSPLY SIRONA by 3.0% during the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock worth $489,000 after purchasing an additional 566 shares during the period. Finally, Envestnet Portfolio Solutions Inc. lifted its holdings in shares of DENTSPLY SIRONA by 6.6% in the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 10,748 shares of the medical instruments supplier’s stock worth $357,000 after purchasing an additional 662 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

XRAY has been the subject of several analyst reports. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a report on Monday, July 22nd. Stifel Nicolaus decreased their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a research report on Thursday, July 18th. Barrington Research reaffirmed an “outperform” rating and set a $38.00 price target on shares of DENTSPLY SIRONA in a report on Monday, July 8th. Evercore ISI decreased their price objective on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday, July 9th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $34.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Five research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $33.44.

DENTSPLY SIRONA Trading Up 0.1 %

Shares of XRAY stock opened at $26.71 on Thursday. The stock has a 50-day simple moving average of $25.52 and a 200 day simple moving average of $27.96. The stock has a market capitalization of $5.41 billion, a P/E ratio of -60.70, a P/E/G ratio of 1.25 and a beta of 1.00. DENTSPLY SIRONA Inc. has a fifty-two week low of $23.58 and a fifty-two week high of $37.60. The company has a quick ratio of 0.87, a current ratio of 1.33 and a debt-to-equity ratio of 0.57.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The business had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. During the same quarter last year, the business posted $0.51 EPS. The business’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, sell-side analysts expect that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, September 27th. This represents a $0.64 annualized dividend and a dividend yield of 2.40%. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.